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Background: Cellular organization of the 
Escherichia coli exoribonuclease RNase II is 
unknown. 
Results: Membrane association and self-
interactions are both required for the RNase II 
cellular organization. 
Conclusion: Membrane binding facilitates RNase 
II interactions leading to assembly into organized 
cellular structures. 
Significance: Interplay of membrane association 
and formation of organized membrane-associated 
cellular structures could provide a mechanism to 
organize multiprotein systems within the bacterial 
cell. 
SUMMARY 
The subcellular localization of the 
exoribonuclease RNase II is not known despite 
the advanced biochemical characterization of 
the enzyme. Here we report that RNase II is 
organized into cellular structures that appear 
to coil around the Escherichia coli cell 
periphery and that RNase II is associated with 
the cytoplasmic membrane by its amino-
terminal amphipathic helix. The helix also acts 
as an autonomous transplantable membrane-
binding domain capable of directing normally 
cytoplasmic proteins to the membrane. 
Assembly of the organized cellular structures of 
RNase II required the RNase II amphipathic 
membrane-binding domain. Co-
immunoprecipitation of the protein from cell 
extracts indicated that RNase II interacts with 
itself. The RNase II self-interaction and the 
ability of the protein to assemble into organized 
cellular structures required the membrane-
binding domain. The ability of RNase II to 
maintain cell viability in the absence of the 
exoribonuclease PNPase was markedly 
diminished when the RNase II cellular 
structures were lost due to changes in the 
amphipathicity of the N-terminal helix, 
suggesting that membrane association and 
assembly of RNase II into organized cellular 
structures play an important role in the normal 
function of the protein within the bacterial cell. 
Bacterial RNA processing and degradation is an 
essential cellular function whose maintenance 
requires the coordinated action of a large number 
of ribonucleases and other proteins. Amongst 
these, RNase II, the 644 amino acid product of the 
Escherichia coli rnb gene, is a processive 
hydrolytic exoribonuclease that acts on the 3' end 
of single-stranded RNA, leading to formation of 5' 
mononucleotides and a short 5' terminal 
oligonucleotide (1). In E. coli, RNase II accounts 
for about 90% of the total exoribonucleolytic 
activity of cell extracts (2). The primary role of 
RNase II appears to be the degradation of mRNA 
(3), although in the absence of other 
exoribonucleases, RNase II also functions in the 
processing of tRNA and other stable RNAs (4,5). 
Although the subcellular location of RNase II is 
not known, the protein is generally regarded as a 
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soluble protein. Here we show that RNase II is a 
membrane-associated protein that binds the 
cytoplasmic membrane via an amino-terminal 
amphipathic alpha-helix. Fluorescence localization 
studies showed that RNase II is organized within 
the cell as membrane-associated ordered 
structures. Membrane binding of RNase II is 
required for assembly of the RNase II organized 
cellular structures, and membrane binding is also 
required for the self-interaction of RNase II in cell 
extracts. Assembly of the RNase II cellular 
structures is required for the normal growth of 
cells that lack the exoribonuclease PNPase, 
suggesting an important role of the RNase II 
higher order cellular organization for the normal 
function of the cell. The functional implications of 
the membrane association in the assembly of the 
organized cellular structures of RNase II and in the 
associated cell functions of the protein are 
discussed. 
EXPERIMENTAL PROCEDURES 
Strains, plasmids and growth conditions- E. coli 
strains were grown in LB medium (6) to which 
100 µg/ml ampicillin, 30 µg/ml kanamycin, 30 
µg/ml chloramphenicol, or 0.4% (w/v) glucose 
were added when indicated. Plasmids and strains 
are listed in Table 1 and the details of their 
construction are available upon request. Gene 
knockouts and yfp fusion to the chromosomal rnb 
gene were constructed by linear DNA 
recombination using λ Red-mediated gene 
replacement (7). HA and Flag-epitope tagging was 
done as previously described (8). P1-mediated 
transduction was used to move mutations to 
different strains (9). 
Microscopy- E. coli cells containing plasmids 
coding for Yfp-labeled proteins were grown at 
30C in the presence of 10 µM IPTG (isopropyl ß-
D-thiogalactoside) (10). Yfp-labeled cells were 
examined by fluorescence microscopy as 
previously described (10). Immunofluorescence 
experiments were done as previously described 
(11), except that the initial centrifugation steps 
were eliminated to avoid possible perturbation of 
protein localization. Cells were fixed in the growth 
medium at room temperature for one hour in the 
presence of 2% formaldehyde and 0.016% 
glutaraldehyde and then adsorbed on silane-coated 
cover slips. Monoclonal mouse anti-HA and 
polyclonal rabbit anti-Flag (Sigma) and Alexa 
fluor 488-conjugated goat anti-mouse and anti-
rabbit antibodies (Molecular Probes) were used to 
detect HA and Flag-tagged RNase II. Images were 
not subjected to deconvolution. 200 to 300 cells 
were analyzed for each strain and the shown 
localization pattern was present in 90-95% of the 
cells. 
Co-immunoprecipitation- Cells that co-express a 
chromosomally encoded RNase II-HA and a 
plasmid-encoded RNase II-Yfp derivative were 
grown at 30C to OD600 0.4 and then the expression 
of the indicated Yfp-labeled proteins was induced 
for 4 hours by growth in the presence of 10 µM 
IPTG. 
Cells that express chromosomally encoded 
RNase II-HA (AT67) or RNase II-Yfp (AT368) 
from the native Prnb promoter were grown under 
the same condition except that IPTG was omitted. 
Equal amounts of AT67 and AT368 cells grown to 
the same cell density were combined in order to 
obtain protein extract containing both 
chromosomally expressed RNase II-HA and 
RNase II-Yfp proteins. 
The cell pellets were washed twice with cold 
PBS buffer (10 mM Na2HPO4, 2 mM KH2PO4, 
137 mM NaCl, 2.7 mM KCl), and then frozen at -
70C. Protein extracts were prepared as previously 
described (12) except that: i. The cells were 
broken in a French pressure cell followed by three 
20 seconds bursts of sonication at 4C; ii. EDTA-
free protease inhibitor cocktail tablets were used in 
all solutions (Roche Diagnostics); iii. The 
ammonium sulfate pellet was resuspended in IP 
buffer (25 mM Tris pH 7.5, 150 mM NaCl, 1 mM 
DTT, 1 mM EDTA, 5% glycerol, 1% NP-40, and 
1X protease inhibitor cocktail). Under these 
conditions 60 to 65 % of RNase II present in 
clarified cell lysates was recovered in the 
ammonium sulfate precipitates as shown by 
quantitative immunoblotting analysis. Protein 
concentrations were determined using a BCA 
assay kit (Pierce). Immunoprecipitations were 
carried out using protein A/G agarose beads 
according to manufacturer's instructions (Pierce) 
and polyclonal anti-HA or anti-Gfp antibodies 
(Santa Cruz Biotechnology), or rabbit IgG 
(Sigma). Beads were first incubated overnight at 
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4C in the presence of 1 mg protein extract in 0.5 
ml IP buffer, and then washed three times with 0.5 
ml IP buffer using spin columns. Retained proteins 
were eluted by incubating the beads for 5 min at 
room temperature in 50 µl elution buffer 
containing primary amine (pH 2.5) (Pierce) and 
then collected by centrifugation in tubes 
containing 3 µl 1M Tris buffer (pH 9.5) to 
neutralize the pH. Boiled samples were 
electrophoresed in 10% SDS mini-polyacrylamide 
gels and then electroblotted to nitrocellulose 
membrane in a Tris-glycine transfer buffer for 70 
min with constant voltage of 100 V. Western blots 
were done using anti-HA and anti-Gfp (which 
binds Yfp protein) combined primary antibodies 
and alkaline phosphatase-conjugated anti-IgG 
secondary antibody (Sigma). When indicated, cell 
extracts were pre-incubated for 15 min at room 
temperature with 5 µg/ml of DNase-free bovine 
pancreatic RNase (Roche Diagnostics) prior to the 
overnight incubation with the beads (13). 
Complete degradation of RNA was obtained 
within 15 min of incubation at room temperature 
in IP buffer when RNase activity was tested on 
protein extracts supplemented with 200 µg/ml of 
yeast RNA (Sigma). 
Membrane isolation- Cells were grown as 
described above for co-immunoprecipitation. Cells 
were broken in a French pressure cell and 
membranes fractions were prepared by a two-step 
sucrose gradient centrifugation as previously 
described (14). The SG0 fraction containing the 
total cell membranes was washed once with 10 ml 
cold HE buffer (10 mM Hepes pH 7.4, 5 mM 
EDTA) and then resuspended in the same buffer. 
To quantitatively assess the RNase II membrane 
association, membrane and cytoplasm cellular 
fractions were prepared by ultracentrifugation of 
cell extracts as previously described (15,16). 
Isolated membranes and cytoplasm were brought 
to the initial volume of the total protein extract and 
equal volumes from each fraction were loaded on 
SDS polyacrylamide gels and subjected to western 
blot analysis using anti-HA and anti-Gfp primary 
antibodies. Band intensities were proportional to 
the amount of protein applied to the gels and were 
quantified by densitometry using the ImageQuant 
program (Molecular Dynamics). 
Immunoblotting analyses- To compare the 
expression levels of the Yfp-labeled RNase II 
derivatives, SDS total cell extracts were made 
using 1 ml culture from cells that were grown as 
indicated above for fluorescence microscopy. Cell 
samples were taken at 2.5, 4.5, 6.5 and 8.5 hours 
after addition of IPTG. The frozen cell pellets 
were resuspended in 10 mM Tris buffer pH 7.5 
containing 1 mM EDTA and 4% SDS and then 
boiled for 5 min. Equal amounts of total protein 
extracts relative to the OD600 of the cultures were 
then separated on 10% polyacrylamide gels and 
electroblotted into nitrocellulose membranes. 
Band intensities were proportional to amounts of 
protein applied to gels. Anti-Gfp primary antibody 
(which binds Yfp protein) and alkaline 
phosphatase-conjugated anti-rabbit IgG secondary 
antibody were used to detect the Yfp-labeled 
RNase II derivatives. 
RESULTS 
Cellular organization of RNase II- Evidence that 
RNase II is organized within the cell and not 
uniformly distributed within the cytoplasm was 
shown by Yfp-labeling of plasmid-encoded RNase 
II and by tagging of the rnb chromosomal gene 
with Flag or HA epitopes, followed by 
fluorescence and immunofluorescence localization 
studies (Fig. 1A-D). RNase II-Yfp, RNase II-HA 
and RNase II-Flag proteins are functional proteins, 
as shown by their ability to restore viability to 
Δpnp Δrnb cells that lack PNPase and RNase II 
(below). 
These studies showed that C-terminally-labeled 
RNase II-Yfp was localized within cellular 
structures that appeared to coil around the cell 
periphery, extending for considerable distances 
along the long axis of the cell (Fig. 1A). 
Immunofluorescence microscopy of cells 
expressing chromosomally encoded RNase II-Flag 
or RNase II-HA, using anti-Flag or anti-HA 
primary antibodies respectively, showed similar 
organized cellular structures (Fig. 1B-C). In 
contrast, N-terminally-labeled Yfp-RNase II 
showed a diffuse localization pattern presumably 
because Yfp obstructed binding of the protein to 
the membrane (see below) (Fig. 1D). 
The cellular localization pattern of RNase II was 
not an artifact of Yfp-labeling (17) or cell fixation 
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since similar RNase II structures were observed 
both by fluorescence microscopy of live RNase II-
Yfp cells and immunofluorescence microscopy of 
fixed cells that expressed RNase II-HA or RNase 
II-Flag. The organized cellular structures were not 
due to RNase II overexpression because similar 
localization patterns were obtained with cells that 
expressed higher than normal levels of plasmid-
encoded RNase II-Yfp and cells that expressed 
chromosomally encoded RNase II-HA or RNase 
II-Flag under control of the native Prnb promoter 
(Fig. 1A-C, 4F2). 
Taken together the data show that RNase II 
exists within the cell as organized structures that 
appear associated with the cell periphery. These 
RNase II cellular structures resemble previously 
described long-range ordered structures of other E. 
coli proteins (11,18). 
RNase II contains an amino-terminal 
amphipathic helix that acts as a membrane-
binding anchor- We noted that the previously 
reported X-ray structure of RNase II shows an 
amino terminal helical domain that extends at 
roughly right angles from the body of the protein 
(Fig. 1I). The N-terminal helix (NTH) is not part 
of the adjacent OB-fold cold shock domain 1 and 
its function has not previously been elucidated 
(19,20). A helical wheel projection of the amino 
acid sequence of the NTH revealed an 
amphipathic character of the helical surfaces, with 
hydrophobic residues clustered on one face and 
polar residues on the other face (Fig. 1J). Because 
amphipathic helices act as membrane-binding 
anchors for other proteins (21-26), we asked 
whether the NTH of RNase II might play a role in 
binding the protein to the cytoplasmic membrane 
and/or in the formation of the organized cellular 
structures of the protein. 
Evidence that RNase II is a membrane-
associated protein and that the NTH domain is 
required for its membrane binding came from cell 
fractionation studies. The strain AT67/pFL4 co-
expressed a chromosomally encoded RNase II-HA 
protein that showed an organized cellular pattern, 
and a plasmid-encoded RNase IIΔ19-Yfp protein 
that lacked the NTH helix domain and showed a 
diffuse cytoplasmic distribution pattern (see 
below). The total membrane fraction isolated by 
sucrose gradient sedimentation (14) was analyzed 
by western blot using anti-Gfp (which interacts 
with Yfp) and anti-HA to identify RNase IIΔ19-
Yfp and RNase II-HA, respectively. As shown in 
Fig. 1K1, the membrane fraction contained the 
full-length HA-tagged RNase II but not the 
derivative that lacked the amphipathic helix 
domain. This shows that RNase II is a membrane-
associated protein and that determinants in the 
NTH domain are required for the binding of the 
protein to the membrane. 
To assess the RNase II membrane association, 
total membrane and cytoplasm fractions were 
isolated by ultracentrifugation (15,16) from the 
strain that co-expressed a chromosomally encoded 
RNase II-HA protein and a plasmid-encoded 
RNase IIΔ19-Yfp protein, and then quantitatively 
analyzed by western blot using anti-Gfp and anti-
HA antibodies. As illustrated in Fig. 1K2, the 
membrane fraction contained approximately 50% 
of the full-length HA-tagged RNase II but 
undetectable amounts of the derivative that lacked 
the amphipathic helix domain. 
Parallel analyses of membrane and cytoplasmic 
fractions using antibodies against the known 
membrane-associated proteins MinD and MreB, 
which bind the membrane through an amphipathic 
helix, also showed approximately 50% of the 
proteins in the membrane fraction (Fig. 1K5-6). 
The presence of a portion of the protein in the 
cytoplasmic fraction may reflect partial 
dissociation of the peripheral membrane proteins 
during the process of cellular breakage and 
fractionation or dynamic membrane association of 
proteins within the cell. 
Evidence that the NTH domain RNase II(1-19) is 
able to act as a transplantable membrane anchor 
that can direct normally cytoplasmic proteins to 
the membrane was obtained from localization 
studies of the Yfp-labeled NTH domain (RNase 
II(1-19)-Yfp) and cell fractionation studies. 
Expression of the Yfp-labeled NTH domain in 
Δrnb cells that lack endogenous RNase II showed 
a peripheral localization pattern characteristic of 
membrane-associated proteins (Fig. 1E). As 
expected, expression of free Yfp resulted in 
diffuse localization of Yfp throughout the 
cytoplasm (Fig. 1F). 
Fractionation of cells that expressed RNase II(1-
19)-Yfp showed similar fractionation pattern as the 
full-length RNase II protein and the membrane 
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associated proteins MinD and MreB, that is, 51% 
of RNase II(1-19) was recovered with the membrane 
fraction (Fig. 1K3). This demonstrates that the 
NTH domain of RNase II can impart membrane-
binding activity to the normally cytoplasmic Yfp 
protein. The NTH domain is therefore an 
autonomous membrane-binding domain. 
The N-terminal helix is required for the RNase II 
cellular organization- To determine whether the 
membrane-binding domain of RNase II plays a 
role in the cellular organization of the protein, we 
carried out localization studies of plasmid-encoded 
Yfp-labeled RNase II derivatives in cells that 
lacked the endogenous rnb gene. Deletion of the 
first 19 residues of RNase II, including the entire 
amphipathic helix, led to loss of the organized 
structures observed with full-length RNase II. 
Instead, the RNase IIΔ19-Yfp was diffusely 
distributed within the cell, indicating a 
cytoplasmic localization (Fig. 1G). In contrast, 
deletion of the three residues that precede and lie 
outside of the amphipathic helix did not affect the 
ability of RNase II to assemble within the 
structures (Fig. 1H), indicating that these residues 
are not required for RNase II membrane binding 
and cellular organization. 
Cellular fractionation studies further confirmed 
the subcellular localization of RNase IIΔ3 and 
RNase IIΔ19. RNase IIΔ19 was exclusively found in 
the cytoplasmic fraction (Fig. 1K2), whereas 
RNase IIΔ3 was associated with the membrane 
fraction, similar to full-length RNase II (Fig. 1K4). 
Taken together with the fact that RNase II(1-19)-Yfp 
was peripherally localized with no evidence of 
organized structures (Fig. 1E), the data indicate 
that membrane binding of RNase II is required but 
is not sufficient for assembly of the organized 
membrane-associated cellular structures that are 
seen with full-length RNase II. 
Role of amphipathicity of the RNase II N-
terminal helix- We next used site-directed 
mutagenesis to address the role of the amphipathic 
character of the NTH in the membrane association 
and cellular organization of RNase II. To disrupt 
the amphipathicity of the helix within the full-
length protein, four leucines of the hydrophobic 
face of the helix (Fig. 2A) were individually 
replaced by the polar amino acid aspartic acid. In 
all cases the Yfp-labeled L7D, L8D, L11D and 
L15D mutant proteins were diffusely distributed 
throughout the cytoplasm (Fig. 2B, F, J, N), 
indicating that the mutant proteins were incapable 
of binding the membrane and assembling into 
organized cellular structures. Diffuse localization 
patterns were also obtained when the mutations 
L7D, L8D, L11D or L15D were introduced into 
the RNase II(1-19)-Yfp protein which contains the 
membrane-binding NTH domain in the absence of 
the rest of the RNase II protein (Fig. 2C, G, K, O), 
confirming that interference with the amphipathic 
nature of the NTH results in loss of membrane 
binding of its NTH domain.  
In contrast, when the leucines were individually 
replaced by other hydrophobic amino acids (valine 
or isoleucine), the RNase II-Yfp L7V, L8V, L11V 
and L15I mutant proteins were organized into 
structures that were indistinguishable from the 
cellular structures formed by wild type RNase II-
Yfp (Fig. 2D, H, L, P, Q). Similarly, replacement 
of polar amino acids with other polar amino acids 
in RNase IIK12E-Yfp and RNase IIH16D-Yfp did not 
affect the ability of the proteins to assemble into 
organized structures (Fig. 2E, I). Consistent with 
the observation that deletion of the residues that 
precede the amphipathic helix did not interfere 
with the normal cellular localization and 
organization of RNase II (Fig. 1H, K4), 
replacement of the second residue phenylalanine 
by lysine did not alter the cellular organization of 
RNase II (Fig. 2M). Quantitative western blot 
analysis showed similar cellular concentrations of 
all of the wild type and mutant proteins, indicating 
that the differences in localization pattern amongst 
the RNase II mutants and derivatives did not come 
from variations in cellular levels of the proteins 
(data not shown). 
Consistent with the fluorescence localization 
studies of the RNase II mutants, cell fractionation 
experiments confirmed that the membrane 
association was completely abolished in L7D 
RNase II and RNase II(1-19) Yfp-labeled mutant 
proteins (Fig. 2R1-2) and was maintained similar 
to the wild type in L7V and K12E RNase II-Yfp 
mutants (Fig. 2R3-4). 
Taken together, the data indicate that the 
amphipathic nature of the NTH is required for 
RNase II membrane association and for the 
organization of RNase II within the cell. 
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Specificity of RNase II amino-terminal 
membrane anchor- To investigate the sequence 
specificity of the NTH in directing the membrane-
binding and cellular organization of RNase II, we 
replaced the RNase II NTH domain with the 
heterologous membrane-binding amphipathic 
helical domain of the MinD protein (MBDMinD) 
(Fig. 3A). MBDMinD was previously shown 
capable of acting as a membrane anchor when 
linked to Gfp or several cytoplasmic proteins 
(22,23,27). As opposed to the N-terminal 
membrane-binding domain of RNase II, MBDMinD 
is located at the carboxyl end of the MinD protein. 
Replacing the RNase II NTH with MBDMinD 
therefore reverses the relative orientation of the 
MBDMinD amino acid sequence and its 
connectivity to MinD protein. Because of the 
possibility that the relative orientation of MBDMinD 
to RNase II protein affects membrane binding, we 
studied the localization patterns of RNase II 
derivatives in which MBDMinD or the reversed 
sequence of MBDMinD (DBMMinD Fig. 3A) 
replaced the RNase II NTH domain. As shown in 
Fig. 3B-C, MBDMinD-RNase IIΔ19-Yfp and 
DBMMinD-RNase IIΔ19-Yfp were localized into 
organized cellular structures independently of the 
orientation of the MinD membrane-binding 
domain. The cellular structures formed by the 
RNase II-MinD chimeras closely resembled the 
structures of the native RNase II protein (Fig. 1A- 
C, 3B-C). We conclude that the ability to support 
the membrane association and the assembly of 
RNase II into organized cellular structures is not 
restricted to the RNase II NTH membrane anchor. 
We also asked whether the RNase II NTH 
domain could substitute for the MBDMinD in 
supporting MinD membrane association and 
formation of the MinD cytoskeletal-like helical 
structures (18). As expected from previous studies, 
deletion of the last 10 residues of MinD, coding 
for the MBDMinD, abrogated the membrane binding 
and the cytoskeletal-like organization of the MinD 
protein (Fig. 3E) (21,28). This was reversed by 
adding the RNase II NTH domain. Thus, the 
chimeric Yfp-MinD(1-260)-NTHRNase II was 
organized into cellular structures that coiled 
around the cell periphery and extended along the 
length of the cell (Fig. 3F). These structures were 
similar to the normal MinD cytoskeletal-like 
helical structures (18). 
These experiments show that the RNase II and 
MinD membrane domains are interchangeable in 
supporting the membrane-binding and higher 
order cellular organization of the RNase II and 
MinD proteins. 
To further investigate the specificity of the 
membrane anchor for the membrane association 
and cellular organization of RNase II, we replaced 
the RNase II NTH domain with the C-terminal 
amphipathic membrane-binding helix of the cell 
division protein FtsA (MBDFtsA) (Fig. 3A). The 
MBDFtsA was previously shown to act as an 
independent membrane anchor when appended to 
other proteins (23,29). 
The chimeric MBDFtsA-RNase IIΔ19-Yfp protein 
was localized at the cell periphery but without any 
higher order organized structures of the protein 
(Fig. 3G). Thus, although the RNase II, MinD and 
FtsA membrane anchors were functionally 
interchangeable in recruiting RNase II to the 
membrane, only the RNase II and MinD MBDs 
were compatible with the assembly of RNase II 
into its characteristic organized cellular structures. 
The properties of these different membrane-
binding domains are further discussed below. 
Role of the membrane anchor in RNase II self-
interaction- Why might membrane association be 
required for formation of the RNase II organized 
cellular arrays? Here we consider the possibility 
that membrane association of RNase II facilitates 
self-interaction of the protein that plays a role in 
the assembly of the RNase II long-range ordered 
cellular structures. 
Evidence for RNase II self-association came 
from co-immunoprecipitation of differentially 
labeled RNase II proteins from protein extracts of 
cells that co-expressed chromosomally encoded 
RNase II-HA and plasmid-encoded RNase II-Yfp. 
Immunoprecipitates (IP) were obtained by using 
protein A/G beads coupled to anti-HA, anti-Gfp or 
IgG antibodies. The immunoprecipitates were then 
analyzed by western blots using anti-HA and anti-
Gfp antibodies simultaneously. This showed the 
presence of both RNase II-HA and RNase II-Yfp 
in the IP fractions obtained with anti-HA beads 
(Fig. 4A1 right panel). Similarly, RNase II-HA 
and RNase II-Yfp were both present in the IP 
fractions obtained by immunoprecipitation with 
anti-Gfp beads (Fig. 4A2). In contrast, no RNase 
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II bands were detected in the IP fraction obtained 
with the IgG control beads (Fig. 4A1 left panel). 
The observed co-immunoprecipitation of RNase 
II-HA and RNase II-Yfp was consistent with 
RNase II-RNase II interactions within the cell 
extract. 
Silver staining of the IP fraction obtained with 
anti-HA beads showed RNase II-HA and RNase 
II-Yfp as the only major bands in addition to the 
IgG bands (data not shown), consistent with direct 
RNase II-RNase II interactions. However, the 
possibility that one or more other proteins 
mediated the observed RNase II-RNase II 
interactions cannot be excluded. 
Evidence that the RNase II interaction was not 
mediated by an RNA bridge (i.e., substrate-
mediated association) came from 
immunoprecipitation of cell extracts that were 
pretreated with bovine pancreatic RNase. RNase 
II-HA and RNase II-Yfp bands were both present 
in the IP fractions obtained from RNase-treated 
extracts using anti-HA beads (Fig. 4A1), 
indicating that the degradation of RNA in the 
protein extracts did not alter the RNase II-RNase 
II interactions. This suggests that RNA does not 
play a role in the observed RNase II-RNase II 
interactions. 
To determine whether the observed RNase II 
self-interaction was due to RNase II-Yfp 
overexpression, we compared parallel co-
immunoprecipitations of differentially labeled 
RNase II proteins from protein extracts of cells 
that expressed RNase II-Yfp from a plasmid under 
the control of the Plac promoter or from the 
chromosomal native Prnb promoter. The cell 
extract that contains both of the chromosomally 
expressed RNase II-HA and RNase II-Yfp proteins 
was obtained by mixing equal amounts of AT67 
and AT368 cells that expressed individual proteins 
respectively. These showed the presence of 
equivalent amounts of RNase II-Yfp in IP 
fractions obtained with anti-HA beads (Fig. 4F1) 
although the cellular level of the chromosomally 
expressed RNase II-Yfp was 10 fold lower 
compared to the level of plasmid-encoded protein 
(Fig. 4F2) as determined by quantitative western 
blots. The fact that similar extents of co-
immunoprecipitation of RNase II-HA and RNase 
II-Yfp were obtained whether or not RNase II-Yfp 
was overexpressed shows that the RNase II 
interactions shown here were not artifacts of 
protein overexpression. 
To determine whether the RNase II self-
interaction required membrane association, we 
asked whether the interaction is dependent on the 
presence of the NTH domain. We performed the 
immunoprecipitation procedure on protein extracts 
from cells that co-expressed RNase II-HA, which 
contains the NTH and forms organized cellular 
structures (Fig. 1C), and RNase IIΔ19-Yfp, which 
fails to form organized structures and is located in 
the cytoplasm (Fig. 1G, K2). This showed that 
only a single band of the cognate RNase II-HA or 
RNase IIΔ19-Yfp was detected in the IP fractions 
obtained by immunoprecipitations with anti-HA or 
anti-Gfp beads, respectively (Fig. 4B right panels). 
We obtained similar results (Fig. 4C) from cells 
that co-expressed RNase II-HA and RNase IIL8D-
Yfp, which failed to form organized membrane-
associated structures (Fig. 2F). Thus, the RNase II-
RNase-II interaction was lost when one of the 
interacting partners lacked the NTH domain 
(RNase IIΔ19-Yfp) or the amphipathicity of its 
NTH domain was disrupted (RNase IIL8D-Yfp). 
These results show that the RNase-II self-
interaction requires the presence of functional 
membrane-binding domains on both interacting 
proteins, implying a requirement for RNase II 
membrane binding by both partners. This suggests 
that the interactions occur subsequent to entry of 
both partners into the membrane. Membrane 
anchors may also interact with small membrane 
vesicles that remained in cell extracts, or with 
lipid-detergent micelles within the amphiphilic 
media used for preparation of cell extracts and the 
immunoprecipitation experiments. 
The data indicate that assembly of the RNase II 
organized cellular structures is associated with the 
ability of the protein to bind the membrane and to 
interact directly or indirectly with itself. 
To ask whether the RNase II interaction is 
specific for the RNase II NTH domain, 
immunoprecipitation experiments were performed 
on extracts from cells that co-expressed RNase II-
HA and a plasmid-encoded RNase II derivative in 
which the NTH domain was replaced by the 
membrane binding domain of MinD or FtsA. As 
shown in Fig. 4D, RNase II-HA and MBDMinD-
RNase IIΔ19-Yfp were both found in the IP 
fractions obtained with anti-HA or anti-Gfp beads 
 at University of Connecticut Health Center Library, on February 19, 2013
w
w
w
.jbc.org
D
ow
nloaded from
 
Cellular organization of RNase II 
 8 
but not detected in the IP fractions obtained with 
IgG control beads. The maintenance of 
interactions between RNase II derivatives that 
carry these different membrane anchors indicates 
that RNase II self-interaction does not occur via 
homotypic interactions between the membrane-
binding anchors. 
In contrast, no interaction was found when 
MBDFtsA replaced the native membrane anchor of 
RNase II-Yfp. As shown in Fig. 4E, only a single 
protein band of RNase II-HA or MBDFtsA-RNase 
IIΔ19-Yfp was detected in the IP fractions obtained 
with anti-HA or anti-Gfp beads, respectively. The 
lack of interaction between RNase II and 
MBDFtsA-RNase IIΔ19 indicates that membrane 
binding of RNase II, although required, is not 
sufficient for the RNase II-RNase II interactions in 
cell extracts. 
The MBDFtsA-RNase IIΔ19 derivative, in contrast 
to MBDMinD-RNase IIΔ19, failed to assemble into 
organized structures despite its membrane 
association (Fig. 3B, G). The FtsA MBD differs 
from the MBDs of RNase II and MinD in the 
higher hydrophobicity of its non-polar face. Thus, 
the hydrophobic moments of the RNase II, MinD 
and FtsA membrane binding domains were 0.373, 
0.554 and 0.716, respectively (30). The FtsA 
MBD also contains more positively charged 
residues on its hydrophilic surface (Fig. 3A), 
increasing its amphipathic character. The possible 
role of these differences on the self-interaction 
properties of RNase II and the ability of the 
protein to assemble high order membrane-
associated structures is discussed below. 
Role of RNase II cellular organization in normal 
cell function- RNase II is essential for the viability 
of cells that lack PNPase, the other major 
exoribonuclease of the cell (3). This provided a 
means to evaluate the functional significance of 
the RNase II membrane association and cellular 
organization. We compared the ability of the 
plasmid-encoded RNase II derivatives to support 
normal growth in Δrnb Δpnp cells (FL4) that 
lacked the chromosomally encoded PNPase and 
RNase II proteins. Expression of RNase II or 
RNase II-Yfp in FL4/Plac-rnb or FL4/Plac-rnb::yfp 
cells in the presence of IPTG supported cell 
growth (Fig. 5A lanes 1-2 (+IPTG)). In contrast 
and consistent with the requirement of RNase II 
for cell viability in the absence of PNPase, 
repression of RNase II or RNase II-Yfp expression 
by growth in the presence of glucose blocked cell 
growth (Fig. 5A lanes 1-2 (+glucose)). Disruptions 
of the amphipathicity of the RNase II NTH that 
lead to cytoplasmic localization of the protein 
(RNase IIL7D, RNase IIL8D) were associated with a 
significant decrease in growth rate of Δrnb Δpnp 
cells (Fig. 5A lanes 2-4; Fig. 5B). In contrast, 
conservative mutations of the NTH of RNase II 
that maintained the normal cellular organization 
pattern of the wild type protein (RNase IIL7V, 
RNase IIL8V) supported normal growth in Δrnb 
Δpnp cells (Fig. 5A lanes 5-6; Fig. 5B). This 
suggested that the ability of RNase II to associate 
with the membrane and/or to assemble into higher 
order organized cellular structures is required for 
the maintenance of normal growth in cells that 
lack PNPase. 
Evidence that the ability of RNase II-Yfp to 
maintain viability of ∆pnp ∆rnb cells was not due 
to overexpression of the plasmid-encoded RNase 
II-Yfp came from comparison of growth rates of 
∆pnp ∆rnb cells whose rnb gene was replaced by a 
plasmid-encoded rnb::yfp under Plac control 
(FL4/pFL3) and ∆pnp cells whose rnb gene was 
replaced by a chromosomally encoded rnb::yfp 
under the native Prnb promoter (AT372). As shown 
in Fig. 5B, both strains grew at similar growth 
rates independently of the expression levels of 
RNase II-Yfp (Fig. 4F2). Thus, the observed 
complementation of ∆pnp ∆rnb cells was not due 
to overexpression of RNase II-Yfp. 
The chimeric RNase II protein in which the 
MBDMinD replaced the RNase II NTH domain, 
which exhibited the normal organization pattern of 
RNase II, behaved similarly to wild type RNase II 
in its ability to restore normal growth to the Δrnb 
Δpnp strain (Fig. 5A lane 7). In contrast the 
MBDFtsA-RNase IIΔ19-Yfp protein that shows 
peripheral localization but fails to assemble the 
normal organized cellular patterns failed to restore 
growth in the Δrnb Δpnp cells. This was shown by 
the inability to produce colonies in the presence of 
a wide range of concentrations of IPTG after the 
attempted introduction of a Δpnp-cat mutation into 
the Δrnb/Plac- MBDFtsA::rnbΔ19::yfp cells by P1 
transduction or by λ Red-mediated gene 
replacement (7,9). This was done under conditions 
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that gave a large number of Δpnp colonies in 
parallel experiments using Δrnb/Plac-rnb or 
Δrnb/Plac-rnb::yfp recipient cells. This indicates 
that RNase II membrane association alone is 
insufficient to restore normal cellular function. 
Taken together, the data suggest that the RNase II 
higher order cellular organization is required for 
normal cell growth in Δpnp cells. 
DISCUSSION 
Localization studies of RNase II, the major 
exoribonuclease of E. coli, using fully functional 
Yfp-labeled and epitope-tagged RNase II proteins, 
showed that the protein is not diffuse within the 
cytoplasm but rather organized as long-range 
cellular structures that appear to coil around the 
cell periphery. The present work also shows that 
an N-terminal amphipathic helix (NTH) of RNase 
II acts as a membrane-binding anchor that is 
required for the assembly of RNase II into 
organized cellular structures. Assembly of the 
RNase II cellular structures is dependent on the 
ability of the protein to bind the cytoplasmic 
membrane via the amphipathic anchor, as shown 
by the observation that deletion of the RNase II 
NTH domain or perturbation of its amphipathicity 
abrogated membrane association and assembly of 
the organized cellular structures. 
It is also clear that assembly of the RNase II 
cellular structures requires determinants outside of 
the membrane anchor. This was shown by the 
inability of the NTH domain of NTH-Yfp to form 
organized cellular structures in the absence of 
other RNase II domains despite the fact that the 
NTH domain alone was capable of recruiting Yfp 
to the membrane. 
Proteins of the E. coli MreBCD and MinCDE 
cytoskeletal-like systems also rely on amphipathic 
helix membrane anchors for their cellular 
organization. The amino-terminal helix of MreB 
and carboxy-terminal helix of MinD respectively 
are required for assembly of MreB cellular 
structures (24) which are essential for cell shape 
maintenance, or for formation of the helically 
organized MinD structures that are required for 
proper placement of the division site at midcell 
(31). In these systems, the membrane anchor is 
located on the surface of the membrane, oriented 
parallel to the bilayer surface. The membrane 
association is mediated by interactions of lipid 
acyl chains of the bilayer with nonpolar amino 
acids chains that extend from one face of the 
amphipathic helix into the bilayer structure 
(24,28,32). A similar mechanism for membrane 
binding is likely for the NTH domain of RNase II 
as this successfully replaced the MBDMinD in 
supporting membrane association and assembly of 
the MinD cytoskeletal-like structures. 
Assembly of the organized RNase II cellular 
structures is also dependent on the ability of the 
protein to interact directly or indirectly with itself, 
as shown by co-immunoprecipitation studies. The 
RNase II interactions require the presence of a 
membrane-binding domain on both interacting 
RNase II partners, implying that membrane 
association is required for the RNase II self-
interactions. It is possible that these interactions 
may also involve interactions between adjacent 
membrane anchor domains. However, the X-ray 
structure of RNase II shows that the NTH domains 
of adjacent molecules are oriented away from each 
other and from the subunit interfaces of the protein 
(20), arguing against the likelihood that direct 
interaction between NTH domains mediates the 
observed RNase II self-interaction.  
The results are compatible with a model in 
which membrane binding of RNase II is associated 
with a change in conformation that leads to RNase 
II self-association that plays a role in its 
subsequent assembly into membrane-associated 
organized cellular structures. The RNase II self-
association shown by co-immunoprecipitation 
from cell extracts could reflect either direct RNase 
II-RNase II interactions or the association of 
RNase II molecules via interactions with other 
components of the RNA processing and 
degradation machinery. 
The RNase II cellular structures were 
maintained when the unrelated MinD MBD 
replaced the RNase II NTH membrane anchor. In 
contrast, assembly of the RNase II organized 
structures was lost when the FtsA MBD directed 
the protein to the membrane. The FtsA MBD 
differs from the MBDs of RNase II and MinD by 
the higher amphipathicity of its helix. MBDFtsA is 
therefore likely to bind more tightly to the 
membrane surface. This could affect the 
conformation or orientation of the membrane-
associated protein, thereby hindering RNase II 
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interactions that are required for assembly of its 
characteristic organized cellular structures. 
It is of interest that many of the proteins 
involved in RNA processing and degradation also 
contain potential membrane-binding domains. 
Thus, the endoribonuclease RNaseE contains an 
internal amphipathic helix that can act as a 
membrane anchor to associate the protein with 
lipid vesicles (33); PAP I contains a potential 
membrane-binding domain within its first 24 
amino acids (34,35); Hfq is localized in close 
proximity to the cytoplasmic membrane in 
electron microscopic studies (36); and the 
endoribonucleases RNase III and RNase P were 
found in inner membrane fractions in cell 
fractionation studies (37). Whether other 
components of the RNA processing and 
degradation are also membrane associated and 
whether membrane-association of these proteins is 
required for their proper cellular organization and 
function, as is the case for RNase II, remains to be 
determined. 
What might be the biological role of the 
membrane association and cellular organization of 
RNase II? Mutations of the NTH that interfered 
with formation of the RNase II organized 
structures were associated with a significant defect 
in the growth of cells that lack PNPase and RNase 
II. This suggests that the cellular organization of 
RNase II might be required for the enzyme to 
carry out essential cellular functions. The growth 
defect could come from loss of the cellular 
organization of RNase II or/and from a direct 
effect of the NTH mutations on the intrinsic 
catalytic activity of the enzyme. Arguing against 
the second possibility are previous studies 
showing that RNase II derivatives with deletions 
of the first 38 or 84 residues of the protein, which 
remove the NTH membrane binding domain, were 
as efficient as full-length RNase II in degrading 
RNA substrates in vitro (38). Nonetheless, it 
remains to be directly determined whether the 
mutations described here, which are restricted to 
individual residues within the NTH domain, 
interfere with the exoribonuclease activity of the 
isolated proteins. 
There are several possible biological roles for 
the assembly of RNase II into its characteristic 
organized membrane-associated structures. i. The 
membrane association may play a regulatory role 
by modulating the enzymatic activity of the 
protein. ii. The cytoplasmic membrane may act as 
a matrix to facilitate interactions of RNase II with 
itself or with other components of the RNA 
processing and degradation machinery by 
increasing the local concentration, due to 
confinement to the two-dimensional membrane 
milieu, or by altering the conformation of the 
protein. iii. The higher order organization of the 
protein might sequester RNase II and other 
components of the cellular RNA processing and 
degradation, such as the RNA degradosome, 
within a common compartment. This could serve 
as a mechanism to bring in close proximity protein 
partners that act cooperatively on their RNA 
substrates, and/or keep the proteins away from the 
cytoplasm to prevent premature degradation of 
RNA substrates. These possibilities are not 
mutually exclusive. Further work will be needed to 
define the nature of the apparent higher order 
RNase II structures in the cell and the role of the 
membrane association and cellular organization of 
the protein in the essential RNA degradation and 
processing functions of the bacterial cell.
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FIGURE LEGENDS 
Figure 1- Role of the amino terminal amphipathic helix in membrane-binding and cellular 
organization of RNase II. 
(A-H) Micrographs of Yfp fluorescence of the plasmid-encoded RNase II proteins in the indicated 
strains and immunofluorescence of the chromosomally encoded Flag or HA-tagged RNase II are shown. 
Panel A- FL1/pFL3 cells (Δrnb/ Plac-rnb::yfp); panel B- AT68 (rnb::Flag); panel C- AT67 (rnb::HA); 
panel D- FL1/pFL1 (Δrnb/ Plac-yfp::rnb); panel E- FL1/pFL13 (Δrnb/ Plac-rnb(1-19)::yfp); panel F- 
MC1000/pAT80 (wt/ Plac-yfp); panel G- FL1/pFL4 (Δrnb/ Plac-rnbΔ19::yfp); panel H- FL1/pFL30 (Δrnb/ 
Plac-rnbΔ(2-4)::yfp). Scale bar = 1 µm. 200 to 300 cells were analyzed for each strain and the shown 
localization pattern was present in 90-95% of the cells (Experimental Procedures). 
(I)- X-ray structure of RNase II showing the amino-terminal helix (red), the nucleic acid binding OB 
fold domains (blue) and the ribonuclease catalytic domain (grey). Image generated according to (19,20), 
using PyMOL molecular graphics system (39) and RNase II protein (protein data bank accession number 
2ID0)3. (J)- Helical wheel projection of the RNase II amino terminal helix using the HeliQuest program 
(30). Nonpolar (yellow), polar noncharged (black) and polar charged residues (blue) are shown. The 
amino-acid sequence of the NTH domain with its secondary structure is shown. 
(K) Western blot analysis of membrane fraction isolated by sucrose gradient centrifugation (14) (panel 
1), and membrane and cytoplasm fractions isolated by ultracentrifugation (15,16) (panels 2-6) using 
monoclonal antibodies anti-HA and anti-Gfp (panels 1-4) or purified polyclonal antibodies anti-MinD 
(panel 5) or anti-MreB (panel 6) and the indicated cellular fractions from cells that co-expressed 
chromosomally encoded HA-tagged RNase II and plasmid-encoded Yfp-labeled RNase II mutants is 
shown. Panels 1-2, 5-6- AT67/pFL4 cells (rnb::HA/ Plac-rnbΔ19::yfp); panel 3- AT67/pFL13 cells 
(rnb::HA/ Plac-rnb(1-19)::yfp); panel 4- AT67/pFL30 cells (rnb::HA/ Plac-rnbΔ(2-4)::yfp). Isolated cellular 
fractions were brought to the same volume as the protein extract and then equal volumes from total 
protein extract (lanes 1-3), membranes (lanes 4-6) and cytoplasm (lanes 7-9) were loaded as indicated. 
Panel 1- 2 µl, 4 µl or 8 µl from each sample were loaded in lanes 1 and 4, lanes 2 and 5, or lanes 3 and 6 
respectively; panels 2-6- 8 µl, 4 µl or 2 µl from each sample were loaded in lanes 1, 4 and 7, lanes 2, 5 
and 8, or lanes 3, 6 and 9 respectively. Arrows indicate positions of protein bands of Yfp-labeled RNase 
II mutants (green), HA-tagged RNase II (white) and MinD (black), arrowhead indicates MreB bands and 
rnb** indicates rnb mutants. 
Figure 2- Role of the amphipathic character of RNase II NTH. 
(A) Helical wheel projection and amino acid sequence of the RNase II amphipathic helix is shown. 
Nonpolar (white), polar (black) and polar charged residues (grey) are shown. The mutated residues are 
shaded in grey in the amino-acid sequence and are marked by stars in the shown helical wheel projection. 
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(B-Q) Fluorescence micrographs of the indicated Yfp-labeled RNase II proteins are shown. Scale bar = 
1 µm. Panel B- FL1/pFL7 cells (Δrnb/ Plac-rnbL7D::yfp); panel C- FL1/pFL16 cells (Δrnb/ Plac-rnb(1-
19)L7D::yfp); panel D- FL1/pFL21 cells (Δrnb/ Plac-rnbL7V::yfp); panel E- FL1/pFL26 cells (Δrnb/ Plac-
rnbK12E::yfp); panel F- FL1/pFL8 cells (Δrnb/ Plac-rnbL8D::yfp); panel G- FL1/pFL17 cells (Δrnb/ Plac-
rnb(1-19)L8D::yfp); panel H- FL1/pFL22 cells (Δrnb/ Plac-rnbL8V::yfp); panel I- FL1/pFL25 cells (Δrnb/ 
Plac-rnbH16D::yfp); panel J- FL1/pFL9 cells (Δrnb/ Plac-rnbL11D::yfp); panel K- FL1/pFL18 cells (Δrnb/ 
Plac-rnb(1-19)L11D::yfp); panel L- FL1/pFL23 cells (Δrnb/ Plac-rnbL11V::yfp); panel M- FL1/pFL31 cells 
(Δrnb/ Plac-rnbF2K::yfp); panel N- FL1/pFL10 cells (Δrnb/ Plac-rnbL15D::yfp); panel O- FL1/pFL20 cells 
(Δrnb/ Plac-rnb(1-19)L15D::yfp); panel P- FL1/pFL24 cells (Δrnb/ Plac-rnbL15I::yfp); panel Q- FL1/pFL3 
cells (Δrnb/ Plac-rnb::yfp). 
(R) Western blot analysis using monoclonal antibodies anti-HA and anti-Gfp (panels 1-4) and indicated 
cellular fractions that were isolated by ultracentrifugation (15,16) from cells that co-expressed 
chromosomally encoded HA-tagged RNase II and plasmid-encoded Yfp-labeled RNase II mutant is 
shown. Panel 1- AT67/pFL7 cells (rnb::HA/ Plac-rnbL7D::yfp); panel 2- AT67/pFL16 cells (rnb::HA/Plac-
rnb(1-19)L7D::yfp); panel 3- AT67/pFL21 cells (rnb::HA/ Plac-rnbL7V::yfp); panel 4- AT67/pFL26 cells 
(rnb::HA/ Plac-rnbK12E::yfp). Samples were applied to gels as indicated in legend to Fig. 1K2-6. Arrows 
and arrowheads indicate positions of protein bands of Yfp-labeled RNase II mutant and HA-tagged 
RNase II respectively, and rnb** indicates rnb mutants. 
Figure 3- The amino-terminal helix of RNase II is a transplantable membrane-binding domain. 
(A)- NTH domain of RNase II and the membrane-binding domains (MBD) of MinD and FtsA are 
shown as helical wheel projections of their corresponding amphipathic terminal helices. MinD and FtsA 
helices are drawn according to previous reports (21,23). MinD DMB is the reversed orientation of the 
amino acid sequence of MinD MBD. N and C indicate the amino and carboxyl termini of the helices. 
(B-G)- Fluorescence micrographs of the Yfp-labeled proteins from the indicated strains are shown. 
Panel B- FL1/pFL11 (Δrnb/ Plac-MBDminD::rnbΔ19::yfp); panel C- FL1/pFL12 (Δrnb/ Plac-
DBMminD::rnbΔ19::yfp); panel D- FL1/pFL4 (Δrnb/ Plac-rnbΔ19::yfp); panel E- RC1/pAT5 (ΔminCDE/ 
Plac-yfp::minDΔ(261-270)); panel F- RC1/pFL15 (ΔminCDE/ Plac-yfp::minDΔ(261-270)::rnb(1-19)); panel G- 
FL1/pFL32 (Δrnb/ Plac-MBDftsA::rnbΔ19::yfp). Δmin cells grew as mixed populations of long and normal 
sized cells as well as minicells (40). Scale bar = 1 µm. 
Figure 4- RNase II self-association. 
Co-immunoprecipitation with anti-HA (A1-E1 (right side) and F1), anti-Gfp (A2-E2 (right side)) or IgG 
(A-E (left side)) beads of protein extract from cells that expressed the indicated RNase II derivatives. 
Protein extracts (PE (3 µg)) and immunoprecipitation fractions, flow through (FT) and immunoprecipitate 
(IP), obtained with the indicated IgG, anti-HA or anti-Gfp beads were subjected to western blots using 
combined anti-HA and anti-Gfp polyclonal (panels A-E) or monoclonal (panel F1) antibodies. Drawings 
depict beads used to obtain the fractions analyzed in the adjacent gel. (A) AT67/pFL3 (rnb::HA/Plac-
rnb::yfp); (B) AT67/pFL4 (rnb::HA/ Plac-rnbΔ19::yfp); (C) AT67/pFL8 (rnb::HA/ Plac-rnbL8D::yfp); (D) 
AT67/pFL11 (rnb::HA/ Plac-MBDminD::rnbΔ19::yfp); (E) AT67/pFL32 (rnb::HA/ Plac-
MBDftsA::rnbΔ19::yfp); (F) AT67/pFL3 (rnb::HA/ Plac-rnb::yfp) (left), AT67 (rnb::HA) + AT368 
(rnb::yfp) (right). To determine the extent of overexpression of the plasmid-encoded RNase II-Yfp same 
(1X) or three-time (3X) protein amounts of cell extracts from AT67/pFL3 and AT67+AT368 cells were 
applied to gels and immunoblotted with monoclonal (F2 top panels) or polyclonal (F2 bottom panels) 
antibodies as indicated. When indicated, protein extracts were pretreated with RNase from bovine 
pancreas as described in Experimental Procedures (panels A1, D2). Empty arrows show the positions of 
Yfp-tagged RNase II derivatives and black arrows show the positions of HA-tagged RNase II bands. 
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Figure 5- Effect of the RNase II mutations on cell growth. 
Complementation assays to compare the ability of the RNase II derivatives to rescue FL4 cells (Δrnb 
Δpnp). (A) Mid-log phase cultures of FL4 strains harboring the indicated plasmids were adjusted to the 
same optical density (OD600), serially diluted (10-1-10-5) and then 1 µl of each culture was spotted on agar 
plates containing 50 µM IPTG or 0.4 % glucose. Similar results were obtained when the plates contained 
150 µM IPTG, or when rnb-HA and rnb-Flag replaced the chromosomal copy of rnb gene in FL2 (Δpnp 
rnb::HA) and FL3 (Δpnp rnb::Flag) cells respectively (data not shown). (B) Growth curves of FL4 and 
AT372 cells expressing under Plac control the indicated plasmid-encoded RNase II-Yfp derivatives in the 
presence of 10 µM IPTG or RNase II-Yfp under the control of Prnb chromosomal promoter are 
respectively shown. The presence of higher IPTG concentrations (50 and 100 µM) gave similar growth. 
White circles- AT372 (∆pnp rnb::yfp); black circles- FL4/pFL3 (Δrnb Δpnp/ Plac-rnb::yfp); white 
squares- FL4/pFL22 (Δrnb Δpnp/ Plac-rnbL8V::yfp); black squares- FL4/pFL21 (Δrnb Δpnp/ Plac-
rnbL7V::yfp); stars- FL4/pFL7 (Δrnb Δpnp/ Plac-rnbL7D::yfp); black triangles- FL4/pFL8 (Δrnb Δpnp/ 
Plac-rnbL8D::yfp). 
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Table 1- Plasmids and strains 
 
Plasmids Relevant Genotype or Description Reference or source 
pMLB1113a Low copy number vector (18 per cell) (40,41) 
pAT5 Plac-yfp::minDΔ(261-270) (27) 
pAT80 Plac-yfp This study 
pFL1 Plac-yfp::rnb This study 
pFL3 Plac-rnb::yfp This study 
pFL4 Plac-rnb∆(1-19)::yfp This study 
pFL6 Plac-rnb This study 
pFL7 Plac-rnbL7D::yfp This study 
pFL8 Plac-rnbL8D::yfp This study 
pFL9 Plac-rnbL11D::yfp This study 
pFL10 Plac-rnbL15D::yfp This study 
pFL11 Plac-MBDminD::rnbΔ(1-19)::yfp (MinD(255-270)) This study 
pFL12 Plac-DBMminD::rnbΔ(1-19)::yfp (MinD(270-255)) This study 
pFL13 Plac-rnb(1-19)::yfp This study 
pFL15 Plac-yfp::minDΔ(261-270)::rnb(1-19) This study 
pFL16 Plac-rnb(1-19)L7D::yfp This study 
pFL17 Plac-rnb(1-19)L8D::yfp This study 
pFL18 Plac-rnb(1-19)L11D::yfp This study 
pFL20 Plac-rnb(1-19)L15D::yfp This study 
pFL21 Plac-rnbL7V::yfp This study 
pFL22 Plac-rnbL8V::yfp This study 
pFL23 Plac-rnbL11V::yfp This study 
pFL24 Plac-rnbL15I::yfp This study 
pFL25 Plac-rnbH16D::yfp This study 
pFL26 Plac-rnbK12E::yfp) This study 
pFL30 Plac-rnb∆(2-4)::yfp This study 
pFL31 Plac-rnbF2K::yfp This study 
pFL32 Plac-MBDftsA::rnbΔ(1-19)::yfp (FtsA(406-420)) This study 
pKD4 kan marker for gene deletion constructs (7) 
pKD46 Red recombinase expression plasmid (7) 
pCP20 FLP expression plasmid (42) 
pSU312 Flag-kan (8) 
pSU315 HA-kan (8) 
Strains Relevant Genotype or Description Reference or source 
MC1000 F- araD139 Δ(araABC-leu)7679 galU galK Δ(lac)X74 rpsL thi (40) 
RC1 MC1000 ∆minCDE-kan (43) 
AT67 MC1000 rnb::HA-kan This study 
AT68 MC1000 rnb::Flag-kan This study 
AT368 MC1000 rnb::yfp-kan This study 
AT372 MC1000 ∆pnp-cat rnb::yfp-kan This study 
FL1 MC1000 ∆rnb-kan This study 
FL2 AT67 ∆pnp-cat This study 
FL3 AT68 ∆pnp-cat This study 
FL4b MC1000 ∆rnb-kan ∆pnp-cat This study 
TM388 ∆pnp-cat (44) 
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a/ Plasmids pAT and pFL are made in pMLB1113 vector. 
b/ Strain not viable unless complemented. 
To allow selection during construction of HA, Flag and yfp chromosomal fusions and deletion strains, a 
kanamycin-resistance cassette was inserted by linear DNA recombination (Experimental Procedures). 
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